Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

740 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South India: A Prospective Cohort Study.
Manesh A, Shankar C, George MM, Jasrotia DS, Lal B, George B, Mathews V, Eapen CE, Joseph P, Subramani K, Rao S, Peter JV, Chacko B, Zachariah A, Sathyendra S, Hansdak SG, Abraham OC, Iyadurai R, Vijayakumar S, Karthik R, Marwick CA, Parcell BJ, Gilbert IH, Veeraraghavan B, Varghese GM. Manesh A, et al. Among authors: lal b. Infect Dis Ther. 2023 May;12(5):1319-1335. doi: 10.1007/s40121-023-00803-3. Epub 2023 Apr 16. Infect Dis Ther. 2023. PMID: 37062023 Free PMC article.
Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae: In Silico and In Vitro Evidence.
Shankar C, Basu S, Lal B, Shanmugam S, Vasudevan K, Mathur P, Ramaiah S, Anbarasu A, Veeraraghavan B. Shankar C, et al. Among authors: lal b. Front Cell Infect Microbiol. 2021 Sep 13;11:709681. doi: 10.3389/fcimb.2021.709681. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34589442 Free PMC article.
India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care.
Veeraraghavan B, Bakthavatchalam YD, Manesh A, Lal B, Swaminathan S, Ansari A, Subbareddy K, Rangappa P, Choudhuri AH, Nagvekar V, Mehta Y, Appalaraju B, Baveja S, Baliga S, Shenoy S, Bhardwaj R, Kongre V, Dattatraya GS, Verma B, Mukherjee DN, Gupta S, Shanmugam P, Iravane J, Mishra SR, Barman P, Chopra S, Hariharan M, Surpam R, Pratap R, Turbadkar D, Taklikar S; Drug Discovery group, Wockhardt. Veeraraghavan B, et al. Among authors: lal b. Indian J Med Microbiol. 2023 Jan-Feb;41:71-80. doi: 10.1016/j.ijmmb.2022.11.005. Epub 2022 Dec 9. Indian J Med Microbiol. 2023. PMID: 36509611 Review.
Combination Versus Monotherapy for Carbapenem-Resistant Acinetobacter Species Serious Infections: A Prospective IPTW Adjusted Cohort Study.
Manesh A, George MM, Palanikumar P, Nagaraj V, Bhanuprasad K, Krishnan R, Nivetha G, Lal B, Triveni KR, Gautam P, George B, Kulkarni U, Mathews V, Subramani K, Rao S, Chacko B, Zachariah A, Sathyendra S, Hansdak SG, Abraham OC, Iyadurai R, Karthik R, Peter JV, Mo Y, Veeraraghavan B, Varghese GM, Paterson DL. Manesh A, et al. Among authors: lal b. Infect Dis Ther. 2024 Nov;13(11):2351-2362. doi: 10.1007/s40121-024-01042-w. Epub 2024 Sep 25. Infect Dis Ther. 2024. PMID: 39322920 Free PMC article.
740 results